// App-Quantinova.ai

3743 : New non-integrative MS2-based lentiviral particles for mRNA delivery: A safe and efficient opportunity for gene editing and immunotherapy applications

Researchers

Presenter

  • Pascale Bouille

Principal Investigators

  • Cedric Auffray

  • Jean-Christophe Pages

  • Christine Duthoit

  • Regis Gayon

Medical Centers

  • VECTALYS, Toulouse, France

  • Universite Francois Rabelais de Tours, INSERM UMR , Tours, France.

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved